Last updated on April 2016

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis


Brief description of study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis

Detailed Study Description

A Phase 3 Study Investigating the Efficacy And Safety of Multiple Dupilumab Dose Gimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis

Clinical Study Identifier: TX143389

Contact Investigators or Research Sites near you

Start Over

IACT Health

Columbus, GA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.